Approval · Notice of Compliance 17561 · 2015
GRASTOFIL: Notice of Compliance 17561
Issued December 7, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17561
- Date
- December 7, 2015
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Hematopoietic agent - granulocyte colony stimulating factor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GRASTOFIL | 02441489 | Marketed |
Medicinal ingredients
- FILGRASTIM (R-METHUG-CSF) 300 MCG per 0.5ML